228 related articles for article (PubMed ID: 7526402)
21. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1.
Edgar JM; McLaughlin M; Werner HB; McCulloch MC; Barrie JA; Brown A; Faichney AB; Snaidero N; Nave KA; Griffiths IR
Glia; 2009 Dec; 57(16):1815-24. PubMed ID: 19459211
[TBL] [Abstract][Full Text] [Related]
22. Myelination in the absence of galactolipids and proteolipid proteins.
Coetzee T; Suzuki K; Nave KA; Popko B
Mol Cell Neurosci; 1999 Jul; 14(1):41-51. PubMed ID: 10433816
[TBL] [Abstract][Full Text] [Related]
23. Decompaction of CNS myelin leads to a reduction of the conduction velocity of action potentials in optic nerve.
Gutiérrez R; Boison D; Heinemann U; Stoffel W
Neurosci Lett; 1995 Aug; 195(2):93-6. PubMed ID: 7478276
[TBL] [Abstract][Full Text] [Related]
24. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse.
Chow E; Mottahedeh J; Prins M; Ridder W; Nusinowitz S; Bronstein JM
Mol Cell Neurosci; 2005 Jul; 29(3):405-13. PubMed ID: 15886014
[TBL] [Abstract][Full Text] [Related]
25. Human myelin proteolipid protein structure and lipid bilayer stacking.
Ruskamo S; Raasakka A; Pedersen JS; Martel A; Škubník K; Darwish T; Porcar L; Kursula P
Cell Mol Life Sci; 2022 Jul; 79(8):419. PubMed ID: 35829923
[TBL] [Abstract][Full Text] [Related]
26. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath.
Bizzozero OA; Bixler HA; Davis JD; Espinosa A; Messier AM
J Neurochem; 2001 Feb; 76(4):1129-41. PubMed ID: 11181833
[TBL] [Abstract][Full Text] [Related]
27. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin.
Montag D; Giese KP; Bartsch U; Martini R; Lang Y; Blüthmann H; Karthigasan J; Kirschner DA; Wintergerst ES; Nave KA
Neuron; 1994 Jul; 13(1):229-46. PubMed ID: 7519026
[TBL] [Abstract][Full Text] [Related]
28. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.
Griffiths I; Klugmann M; Anderson T; Yool D; Thomson C; Schwab MH; Schneider A; Zimmermann F; McCulloch M; Nadon N; Nave KA
Science; 1998 Jun; 280(5369):1610-3. PubMed ID: 9616125
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of proteolipid protein peptide 103-116 in myelin.
Sobel RA; Greer JM; Isaac J; Fondren G; Lees MB
J Neurosci Res; 1994 Jan; 37(1):36-43. PubMed ID: 7511704
[TBL] [Abstract][Full Text] [Related]
30. Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis.
Bradl M; Bauer J; Inomata T; Zielasek J; Nave KA; Toyka K; Lassmann H; Wekerle H
Acta Neuropathol; 1999 Jun; 97(6):595-606. PubMed ID: 10378378
[TBL] [Abstract][Full Text] [Related]
31. Demyelination in a transgenic mouse: a model for multiple sclerosis.
Mastronardi FG; Ackerley CA; Arsenault L; Roots BI; Moscarello MA
J Neurosci Res; 1993 Oct; 36(3):315-24. PubMed ID: 7505836
[TBL] [Abstract][Full Text] [Related]
32. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice.
Wight PA; Duchala CS; Readhead C; Macklin WB
J Cell Biol; 1993 Oct; 123(2):443-54. PubMed ID: 8408224
[TBL] [Abstract][Full Text] [Related]
33. Insertion of mutant proteolipid protein results in missorting of myelin proteins.
Vaurs-Barriere C; Wong K; Weibel TD; Abu-Asab M; Weiss MD; Kaneski CR; Mixon TH; Bonavita S; Creveaux I; Heiss JD; Tsokos M; Goldin E; Quarles RH; Boespflug-Tanguy O; Schiffmann R
Ann Neurol; 2003 Dec; 54(6):769-80. PubMed ID: 14681886
[TBL] [Abstract][Full Text] [Related]
34. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage.
Readhead C; Schneider A; Griffiths I; Nave KA
Neuron; 1994 Mar; 12(3):583-95. PubMed ID: 7512350
[TBL] [Abstract][Full Text] [Related]
35. Gene expression and oligodendrocyte development in the myelin deficient rat.
Nadon NL; Duncan ID
J Neurosci Res; 1995 May; 41(1):96-104. PubMed ID: 7674382
[TBL] [Abstract][Full Text] [Related]
36. Mammalian-Specific Central Myelin Protein Opalin Is Redundant for Normal Myelination: Structural and Behavioral Assessments.
Yoshikawa F; Sato Y; Tohyama K; Akagi T; Furuse T; Sadakata T; Tanaka M; Shinoda Y; Hashikawa T; Itohara S; Sano Y; Ghandour MS; Wakana S; Furuichi T
PLoS One; 2016; 11(11):e0166732. PubMed ID: 27855200
[TBL] [Abstract][Full Text] [Related]
37. Current concepts of PLP and its role in the nervous system.
Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
[TBL] [Abstract][Full Text] [Related]
38. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
39. Myelin proteolipid protein: function in myelin structure is distinct from its role in oligodendrocyte development.
Nadon NL; West M
Dev Neurosci; 1998; 20(6):533-9. PubMed ID: 9858842
[TBL] [Abstract][Full Text] [Related]
40. Effects of osmolality on PLP-null myelin structure: implications re axon damage.
Rosenbluth J; Schiff R; Lam P
Brain Res; 2009 Feb; 1253():191-7. PubMed ID: 19094971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
